{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:19:41Z","timestamp":1793272781417,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"am","delay-in-days":286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18K06767"],"award-info":[{"award-number":["18K06767"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.tiv.2023.105606","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T14:28:14Z","timestamp":1683124094000},"page":"105606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Mechanism of non-steroidal anti-androgen-induced liver injury: Reactive metabolites of flutamide and bicalutamide activate inflammasomes"],"prefix":"10.1016","volume":"90","author":[{"given":"Ryuji","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Ijiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2023.105606_bb0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1025560513308","article-title":"Flutamide-induced hepatic dysfunction in relation to steady-state plasma concentrations of flutamide and its metabolites","volume":"252","author":"Aizawa","year":"2003","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.tiv.2023.105606_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-032414-112116","article-title":"Endoplasmic reticulum stress in immunity","volume":"33","author":"Bettigole","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tiv.2023.105606_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-005-1016-1","article-title":"Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer","volume":"56","author":"Boccardo","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tiv.2023.105606_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","article-title":"How reactive metabolites induce an immune response that sometimes leads to an idiosyncratic drug reaction","volume":"30","author":"Cho","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2023.105606_bb0025","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00003088-200443130-00003","article-title":"Bicalutamide: clinical pharmacokinetics and metabolism","volume":"43","author":"Cockshott","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tiv.2023.105606_bb0030","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1021\/tx7001349","article-title":"Comparison of the cytotoxicity of the nitroaromatic drug flutamide to its cyano analogue in the hepatocyte cell line TAMH: evidence for complex I inhibition and mitochondrial dysfunction using toxicogenomic screening","volume":"20","author":"Coe","year":"2007","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2023.105606_bb0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40262-015-0271-5","article-title":"Clinical pharmacokinetic studies of enzalutamide","volume":"54","author":"Gibbons","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tiv.2023.105606_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106017","article-title":"Dexamethasone alleviate allergic airway inflammation in mice by inhibiting the activation of NLRP3 inflammasome","volume":"78","author":"Guan","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.tiv.2023.105606_bb0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.tiv.2023.105606_bb0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tiv.2023.105606_bb0055","first-page":"54","article-title":"Regorafenib and reactive metabolite of Sunitinib activate Inflammasomes: implications for multi tyrosine kinase inhibitor-induced immune related adverse events","volume":"77","author":"Kato","year":"2022","journal-title":"Pharmazie"},{"key":"10.1016\/j.tiv.2023.105606_bb0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.chemrestox.7b00065","article-title":"Supernatant from hepatocyte cultures with drugs that cause idiosyncratic liver injury activates macrophage Inflammasomes","volume":"30","author":"Kato","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2023.105606_bib141","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2131\/jts.45.673","article-title":"Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction","volume":"45","author":"Kato","year":"2020","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tiv.2023.105606_bb0065","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1248\/bpb.b14-00438","article-title":"Human hepatocarcinoma functional liver cell-4 cell line exhibits high expression of drug-metabolizing enzymes in three-dimensional culture","volume":"37","author":"Kato","year":"2014","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tiv.2023.105606_bb0070","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1124\/dmd.119.087981","article-title":"The 2-Hydroxyiminostilbene metabolite of carbamazepine or the supernatant from incubation of hepatocytes with carbamazepine activates Inflammasomes: implications for carbamazepine-induced hypersensitivity reactions","volume":"47","author":"Kato","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2023.105606_bb0075","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1021\/acs.chemrestox.1c00127","article-title":"Amiodarone, unlike Dronedarone, activates Inflammasomes via its reactive metabolites: implications for amiodarone adverse reactions","volume":"34","author":"Kato","year":"2021","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2023.105606_bb0080","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00280-017-3417-3","article-title":"Phase 1 study of darolutamide (ODM-201): a new-generation androgen receptor antagonist, in Japanese patients with metastatic castration-resistant prostate cancer","volume":"80","author":"Matsubara","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.tiv.2023.105606_bb0085","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tiv.2023.105606_bb0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/dmd.108.021964","article-title":"Role of enzymatic N-hydroxylation and reduction in flutamide metabolite-induced liver toxicity","volume":"37","author":"Ohbuchi","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2023.105606_bb0095","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.pcan.4500564","article-title":"Caffeine test in predicting flutamide-induced hepatic injury in patients with prostate cancer","volume":"5","author":"Ozono","year":"2002","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.tiv.2023.105606_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/bdd.2000","article-title":"In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in rats","volume":"37","author":"Parrish","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.tiv.2023.105606_bb0105","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/j.1552-4604.1989.tb03381.x","article-title":"Single and multiple dose pharmacokinetic evaluation of flutamide in normal geriatric volunteers","volume":"29","author":"Radwanski","year":"1989","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2023.105606_bb0110","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2013.50.1684","article-title":"Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer","volume":"31","author":"Rathkopf","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tiv.2023.105606_bb0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine induces an acute proinflammatory response that is attenuated by inhibition of inflammasome signaling: implications for idiosyncratic drug-induced agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2023.105606_bb0120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/tx400098z","article-title":"12-OH-nevirapine sulfate, formed in the skin, is responsible for nevirapine-induced skin rash","volume":"26","author":"Sharma","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2023.105606_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-018-1214-5","article-title":"HSP60 critically regulates endogenous IL-1\u03b2 production in activated microglia by stimulating NLRP3 inflammasome pathway","volume":"15","author":"Swaroop","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tiv.2023.105606_bb0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1081\/DMR-120005667","article-title":"N-oxidation of drugs associated with idiosyncratic drug reactions","volume":"34","author":"Uetrecht","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.tiv.2023.105606_bb0135","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1124\/jpet.111.188508","article-title":"Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs: relevance to their pharmacological activity","volume":"340","author":"Wong","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2023.105606_bb0140","doi-asserted-by":"crossref","first-page":"E2846","DOI":"10.3390\/molecules23112846","article-title":"Heat shock proteins as Immunomodulants","volume":"23","author":"Zininga","year":"2018","journal-title":"Molecules"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233323000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233323000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:43:31Z","timestamp":1760136211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233323000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":29,"alternative-id":["S0887233323000553"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2023.105606","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of non-steroidal anti-androgen-induced liver injury: Reactive metabolites of flutamide and bicalutamide activate inflammasomes","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2023.105606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105606"}}